Relmada Therapeutics

Relmada Therapeutics RLMD Stock

$3.02   0.166393%
Add to favorites
Market Cap
$321.68M
LOW - HIGH [24H]
$2.96 - $3.09
VOLUME [24H]
$301.41K
P/E Ratio
0
Earnings per share
-$0.73
ISIN
US75955J4022
Price   Prediction

Relmada Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Relmada Therapeutics (RLMD) stock price today is 3.02 USD on Tech Market Small (+0.17% on the day). Updated .

Relmada Therapeutics RLMD Financial and Trading Overview

Relmada Therapeutics stock price 3.02 USD
Previous Close 4.21 USD
Open 4.11 USD
Bid 2.9 USD x 200
Ask 4.44 USD x 200
Day's Range 3.46 - 4.14 USD
52 Week Range 3.07 - 8 USD
Volume 2.42M USD
Avg. Volume 1.36M USD
Market Cap 385.17M USD
Beta (5Y Monthly) 0.574
PE Ratio (TTM) N/A
EPS (TTM) -0.73 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 10.75 USD

RLMD Valuation Measures

Enterprise Value 181.44M USD
Trailing P/E N/A
Forward P/E -8.804878
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.8646693
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Relmada Therapeutics Stock Price History

Beta (5Y Monthly) 0.574
52-Week Change 6.04%
S&P500 52-Week Change 13.32%
52 Week High 8 USD
52 Week Low 3.07 USD
50-Day Moving Average 3.77 USD
200-Day Moving Average 5.37 USD

RLMD Share Statistics

Avg. Volume (3 month) 1.36M USD
Avg. Daily Volume (10-Days) 1.63M USD
Shares Outstanding 106.69M
Float 82.14M
Short Ratio 6.97
% Held by Insiders 3.60%
% Held by Institutions 99.43%
Shares Short 10.84M
Short % of Float 10.78%
Short % of Shares Outstanding 10.16%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:4

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -36.90%
Return on Equity (ttm) -64.66%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -65696088 USD
Diluted EPS (ttm) -0.91
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 202.12M USD
Total Cash Per Share (mrq) 1.89 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 26.371
Book Value Per Share (mrq) 1.936

Cash Flow Statement

Operating Cash Flow (ttm) -51855448 USD
Levered Free Cash Flow (ttm) -28620364 USD

Profile of Relmada Therapeutics

Country United States
State FL
City Coral Gables
Address 2222 Ponce de Leon Blvd.
ZIP 33134
Phone 786 629 1376
Website https://www.relmada.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 17

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.

Q&A For Relmada Therapeutics Stock

What is a current RLMD stock price?

Relmada Therapeutics RLMD stock price today per share is 3.02 USD.

How to purchase Relmada Therapeutics stock?

You can buy RLMD shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Relmada Therapeutics?

The stock symbol or ticker of Relmada Therapeutics is RLMD.

Which industry does the Relmada Therapeutics company belong to?

The Relmada Therapeutics industry is Biotechnology.

How many shares does Relmada Therapeutics have in circulation?

The max supply of Relmada Therapeutics shares is 106.69M.

What is Relmada Therapeutics Price to Earnings Ratio (PE Ratio)?

Relmada Therapeutics PE Ratio is now.

What was Relmada Therapeutics earnings per share over the trailing 12 months (TTM)?

Relmada Therapeutics EPS is -0.73 USD over the trailing 12 months.

Which sector does the Relmada Therapeutics company belong to?

The Relmada Therapeutics sector is Healthcare.

Relmada Therapeutics RLMD included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24462.84 USD —
+0.55
1.95B USD — 24268.03 USD — 24538.78 USD — — 1.95B USD —
us US Tech Global Select Market Com NQGS US 12051.6 USD —
+0.56
— — 11954.49 USD — 12087.35 USD — — — —
us US Tech Biotechnology NBI US 7061.95 USD —
+0.63
— — 6976.59 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1340.2 USD —
+0.55
— — 1325.21 USD — 1342.46 USD — — — —
us US Tech Capital Market Composite RCMP US 109.88 USD —
+1.09
— — 108.35 USD — 109.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.18T
Total marketcap
$71.41B
Total volume
BTC 58.24%   •   ETH 9.87%
Dominance
Select currency